A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers

Journal of Pathology

Volumn 182, Issue 1, 1997, Pages 13-21

  Senden, Nicole H M ^a   Timmer, Erika D J ^a   De Bruïne, Adriaan ^b   Wagenaar, Sjoerd Sc ^b,c   Van De Velde, Helgi J K ^d   Roebroek, Anton J M ^d   Van De Ven, Wim J M ^d   Broers, Jos L V ^a   Ramaekers, Frans C S ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

chromogranin A; NCAM; neurofilament proteins; NSP reticulons; synaptophysin

Indexed keywords

CD57 ANTIGEN; CHROMOGRANIN A; NERVE CELL ADHESION MOLECULE; NEUROFILAMENT PROTEIN; SYNAPTOPHYSIN;

ARTICLE; DIAGNOSTIC VALUE; DISEASE MARKER; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOID TUMOR; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; LUNG NEOPLASMS; NERVE TISSUE PROTEINS; NEUROENDOCRINE TUMORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030909413     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199705)182:1<13::AID-PATH804>3.0.CO;2-Z     Document Type: Article

References (35)

1. Senden NHM, Van de Velde HJK, Broers JLV, et al. Cluster 10 lung cancer antibodies recognize NSPs, novel neuroendocrine proteins associated with membranes of the endoplasmic reticulum. Int J Cancer: 1994; Suppl 8: 84-88.
2. Van de Velde HJK, Senden NHM, Roskams TAD, et al. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis. Cancer Res 1994; 54: 4769-4776.
3. Senden NHM, Timmer EDJ, Boers JE, et al. Neuroendocrine-specific protein C (NSP-C): subcellular localization and differential expression in relation to NSP-A. Eur J Cell Biol 1996; 69: 197-213.
4. Senden NHM, Linnoila RI, Timmer EDJ, et al. NSP-reticulons as independent markers for non-small cell lung cancer with neuroendocrine differentiation. An in vitro histochemical study. (Submitted).
5. Shaw GL, Gazdar AF, Phelps R, et al. Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing. Cancer Res 1993; 53: 5181-5187.
6. The World Health Organization histological typing of lung tumours. Am J Clin Pathol 1982; 77: 123-136.
7. Senden NHM, Van de Velde HJK, Broers JLV, et al. Subcellular localization and supramolecular organization of neuroendocrine-specific protein B (NSP-B) in small cell lung cancer. Eur J Cell Biol 1994; 65: 341-353.
8. Van de Velde HJK, Roebroek AJM, Van Leeuwen FW, Van de Ven WJM. Molecular analysis of expression in rat brain of NSP-A. a novel neuroendocrine-specitic protein of the endoplasmic reticulum. Mol Brain Res 1994; 23: 81-92.
9. Van de Velde HJK. Roebroek AJM. Senden NHM. Ramaekers FCS. Van de Ven WJM. NSP-reticulons. neuroendocrine proteins of a novel gene family associated with membranes of the endoplasmic reticulum. J Cell Sci 1994; 107: 2403-2416.
10. Wiedenmann B. Huttner WB. Synaptophysin and chromogranins/ secretogranins. widespread constituents of distinct types of neuroendocrine Nesicles and new tools in tumour diagnosis. Virchows Arch B [Cell Pathol] 1989; 58: 95-121.
11. Klück P, van Muyen GNP, van der Kamp AWM, et al. Hirschsprung's disease studied with monoclonal antineurofilament antibodies, on tissue sections. Lancet 1984; 1: 652-654.
12. Nakazato Y. Sasaki A, Hirato J, Ishida Y. Immunohistochemical localization of neurofilament protein in neuronal degenerations. Acta Neuropathol 1984; 64: 30-36.
13. Broers JLV, Ramaekers FCS, Klein Rot M, et al. Cytokeratins in different types of lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res 1988; 48: 3221-3229.
14. Stahel RA, Gilks WR, Lehmann H-P, Schenker T. Third International Workshop on Lung Tumour and Differentiation antigens: overview of the results of the central data analysis. Int J Cancer 1994; Suppl 8: 6-26.
15. Broers JLV, Klein Rot M, Oostendorp T, et al. Immunocytochemical detection of lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens. Cancer Res 1987; 47: 3225-3224.
16. Kibbelaar RE, Moolenaar KEC, Michalides RJAM, et al. Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma. Eur J Cancer 1991; 27: 431-435.
17. Schol DJ, Mooi WJ, van der Gugten AA, Wagenaar SS, Hilgers J. Monoclonal antibody 123c3, identifying small cell lung carcinoma phenotype in lung tumours, recognizes mainly, but not exclusively, endocrine and neuron-supporting normal tissues. Int J Cancer 1988; Suppl 2: 34-40.
18. Lee I, Gould VE, Moll R, Wiedenmann B, Franke WW, Synaptophysin expressed in the bronchopulmonary tract: neuroendocrine cells, neuroepithelial bodies and neuroendocrine neoplasms. Differentiation 1987; 34: 115-125.
19. Loy TS, Darkow GVD, Quesenberry JT. Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations. Am J Surg Pathol 1995; 19: 173-182.
20. De Bruïne AP, Bosman FT. Neuroendocrine tumours in the respiratory tract. Acta Histovhem, Suppl 1990; XXXVIII: 99-105.
21. Jensen SM, Gazdar AF, Cuttitta F, Russell EK, Linnoila RI. A comparison of synaptophysin, chromogranin and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Cancer Res 1990; 50: 6068-6074.
22. Gazdar A, Helman L, Israel M, et al. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A and dense core granules in human tumours of endocrine and non-endocrine origin. Cancer Res 1988; 48: 4078-4082.
23. Marthy-Ane CH, Costes V, Pujol JL, Alauzen M, Baldet P, Mary H. Carcinoid tumours of the lung: do atypical features require aggressive management? Ann Thorac Surg 1995; 59: 78-83.
24. Linnoila RI, Mulshine JL, Steinberg SM, et al. Neuroendocrine differentiation in endocrine and non-endocrine lung carcinomas. Am J Clin Pathol 1988; 6: 641-652.
25. Tötsch M, Müller LC, Hittmair A, Offner D, Gibbs A. Schmid KW. Immunohistochemical demonstration of chromogranins A and B in neuroendocrine tumours of the lung. Hum Pathol 1992; 23: 312-316.
26. Kiriakogiani-Psarapoulou P, Malamou-Mitsi V, Martinopoulou U. et al. The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study. Lung Cancer 1994; 11: 353-364.
27. Haimoto H, Takahashi Y, Koshikavva T, Nagura H, Kato K. Immunohistochemical localization of gamma enolase in normal human tissues other than nervous and neuroendocrine tissues. Lab Invest 1985; 52: 257-263.
28. Said JW, Vimadalal S, Nash G, et al. Immunoreactive neuron-specific enolase, bombesin and chromogranin as markers for neuroendocrine lung tumours. Hum Pathol 1985; 16: 236-240.
29. Dardick I, Rippstein P, Perkins G. Reliability of criteria for ultrastructural identification of neuroendocrine granules. Ultrastruc Pathol 1993; 17: 37-47.
30. Berendsen HH, De Leij L, Poppema S, Postmus PE, Boes A, Sluiter HJ. Clinical characterization of non-small cell lung cancer tumours showing neuroendocrine differentiation features. J Clin Oncol 1989; 7: 1614-1620.
31. Sundaresan V, Reeve JG, Stenning S, Stewart S, Bleehen NM. Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours. Br J Cancer 1991; 64: 333-338.
32. Graziano SL, Tatum AH, Newman NB, et al. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Cancer Res 1994; 54: 2908-2913.
33. Skov BG, Sorensen BJ, Hirsch FR, Larsson LI, Hansen HH. Prognostic impact of histologic demonstration of chromogranin A and neuron-specific enolase in pulmonary adenocarcinoma. Ann Oncol 1991; 2: 355-360.
34. Graziano SL, Mazid R, Newman N, et al. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer. J Clin Oncol 1989; 7: 1398-1406.
35. Souhami RL. Neuroendocrine phenotype. chemosensitivity and prognosis in adenocarcinoma of the lung. Ann Oncol 1991; 2: 323-324.